Connor, Clark & Lunn Investment Management (CC&L)’s Denali Therapeutics DNLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-61,096
| Closed | -$1.7M | – | 1295 |
|
|
2022
Q4 | $1.7M | Sell |
61,096
-51,436
| -46% | -$1.43M | 0.01% | 585 |
|
|
2022
Q3 | $3.45M | Buy |
+112,532
| New | +$3.45M | 0.02% | 394 |
|
|
2021
Q3 | – | Sell |
-19,993
| Closed | -$1.57M | – | 1088 |
|
|
2021
Q2 | $1.57M | Sell |
19,993
-17,913
| -47% | -$1.4M | 0.01% | 594 |
|
|
2021
Q1 | $2.16M | Buy |
37,906
+18,229
| +93% | +$1.04M | 0.01% | 545 |
|
|
2020
Q4 | $1.65M | Buy |
+19,677
| New | +$1.65M | 0.01% | 544 |
|